Scienture LLC Products

Treating the Experience.

Moving beyond traditional therapies, we aim to improve adherence journeys for patients’ needs.

Our Products

Arbli™ (losartan potassium) oral suspension 10 mg/ mL

First commercially available, FDA-approved oral liquid losartan potassium for cardiovascular use.

View Press Release

Rezenopy™ (naloxone HCl) nasal spray 10 mg

The most potent, highest strength, FDA-approved naloxone nasal spray on the U.S. market.

View Press Release

Our Pipeline

Indication

Early Development

Animal Studies

Human Studies

Phase 1

Phase 2

Phase 3

Anticipated NDA/BLA Submission Status

SCN-104 | CNS/Pain

Drug device combination for convenient self-injection

SCN-106 | CVS

Biosimilar product for hospital use

SCN-107 | CNS/Pain

Long-acting injection for post-operative care

Completed

To be performed

Indication

SCN-104 | CNS/Pain

Drug device combination for convenient self-injection

Early Development

Animal Studies

Human Studies

Phase 1

Phase 2

Phase 3

Indication

SCN-106 | CVS

Biosimilar product for hospital use

Early Development

Human Studies

Phase 1

Phase 2

Phase 3

Indication

SCN-107 | CNS/Pain

Long-acting injection for post-operative care

Early Development

Animal Studies

Human Studies

Phase 1

Phase 2

Phase 3


Completed

To be performed

Nurse holding a patient's hands.

Partnering for Impactful Solutions

At Scienture, we value bold ideas grounded in evidence-based solutions, balancing innovation with measurable impact on patient care.

Contact us to explore partnership opportunities in product licensing, co-marketing, or asset acquisitions to shape the future of healthcare together.

Contact Us

Latest News